Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

SARS-CoV-2 target regions

enabled by data from GSAID Logo

EPI_ISL ID Virus name Region Country Collection Date Navigate
EPI_ISL ID: EPI_ISL_19389731 Virus name: hCoV-19/Canada/ON-PHL-202413042/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19389730 Virus name: hCoV-19/Canada/ON-PHL-202413041/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19389719 Virus name: hCoV-19/Canada/ON-PHL-202413030/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19389718 Virus name: hCoV-19/Canada/ON-PHL-202413029/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19389716 Virus name: hCoV-19/Canada/ON-PHL-202413027/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19389680 Virus name: hCoV-19/Canada/ON-PHL-202412990/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19389518 Virus name: hCoV-19/Canada/ON-PHL-202412818/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19389517 Virus name: hCoV-19/Canada/ON-PHL-202412817/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19389511 Virus name: hCoV-19/Canada/ON-PHL-202412811/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19385993 Virus name: hCoV-19/Spain/PV-HUD-39206556/2024 Region: Europe Country: Spain Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19385988 Virus name: hCoV-19/Spain/PV-HUD-96017812/2024 Region: Europe Country: Spain Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19385982 Virus name: hCoV-19/Spain/PV-HUD-72235538/2024 Region: Europe Country: Spain Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19385979 Virus name: hCoV-19/Spain/PV-HUD-70137753/2024 Region: Europe Country: Spain Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19385978 Virus name: hCoV-19/Spain/PV-HUD-70137727/2024 Region: Europe Country: Spain Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19384363 Virus name: hCoV-19/Canada/NB-CHUDGLD-01I-MM00031R/2024 Region: North America Country: Canada Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19383577 Virus name: hCoV-19/USA/IA-SHL-2488289/2024 Region: North America Country: USA Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19383573 Virus name: hCoV-19/USA/IA-SHL-2488291/2024 Region: North America Country: USA Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19383554 Virus name: hCoV-19/USA/IA-SHL-2488293/2024 Region: North America Country: USA Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19383523 Virus name: hCoV-19/USA/IA-SHL-2488290/2024 Region: North America Country: USA Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19383074 Virus name: hCoV-19/Japan/FR050-0274/2024 Region: Asia Country: Japan Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19383071 Virus name: hCoV-19/Japan/FR050-0267/2024 Region: Asia Country: Japan Collection Date: 2024-09-01 Go to details
EPI_ISL ID: EPI_ISL_19393526 Virus name: hCoV-19/Canada/ON-KHS-04161-v1/2024 Region: North America Country: Canada Collection Date: 2024-08-31 Go to details
EPI_ISL ID: EPI_ISL_19389824 Virus name: hCoV-19/Canada/ON-PHL-202413143/2024 Region: North America Country: Canada Collection Date: 2024-08-31 Go to details
EPI_ISL ID: EPI_ISL_19389806 Virus name: hCoV-19/Canada/ON-PHL-202413125/2024 Region: North America Country: Canada Collection Date: 2024-08-31 Go to details
EPI_ISL ID: EPI_ISL_19383076 Virus name: hCoV-19/Japan/FR050-0262/2024 Region: Asia Country: Japan Collection Date: 2024-08-31 Go to details

Pre-calculated values are obtained by using ThermonucleotideBLAST (Gans JD, Wolinsky M. 2008), which performs in silico simulations with the NAAT methods stored in our database on the selected high-quality (<1% Ns and <0.05% unique amino acid mutations) and full length (>29,000bp) viral genomes made available by GISAID. The aims are both to detect potential target regions of the NAAT methods and to highlight possible differences with the expected reference sequence which might affect the NAAT performance.

The database contains amplicons collected by screening viral shared genomic sequences of SARSCoV- 2 by in silico determination of PCR-based molecular assays to diagnose COVID-19. The information is retrieved periodically. Acknowledgements

GISAID data provided on this website are subject to GISAID's Terms and Conditions